SCC

Squamous Cell Carcinoma is a malignant tumor that arises from the squamous epithelial cells, the flat, scale-like cells that form the outermost layer of the skin and line the surfaces of the mouth, throat, and other mucosal tissues. It is one of the most common malignant skin tumors in dogs and also represents a significant category of oral neoplasia. The behavior of SCC varies considerably depending on the anatomic location, with cutaneous forms often carrying a more favorable prognosis than oral or subungual variants.

The development of squamous cell carcinoma involves the malignant transformation of normal keratinocytes, the predominant cell type in the epidermis. This transformation results from accumulated genetic mutations that disrupt normal cell growth regulation, leading to uncontrolled proliferation, local tissue invasion, and in some cases, metastatic spread to distant sites. The mutations driving SCC development may arise from environmental exposures such as chronic ultraviolet radiation damage, from papillomavirus infection in certain cases, or from poorly understood intrinsic factors that predispose certain breeds and individuals.

Cutaneous SCC in dogs most commonly affects lightly pigmented or hairless skin areas that receive chronic sun exposure, including the ventral abdomen, inguinal region, and nasal planum. These tumors tend to be locally invasive but have relatively low metastatic rates, typically below 20 percent, making early surgical excision curative in many cases. The relationship between UV exposure and cutaneous SCC is well established and parallels the association between sun exposure and skin cancer in humans, making dogs with light skin and sparse hair coats particularly vulnerable.

Oral and subungual (nail bed) forms of SCC behave more aggressively than most cutaneous variants. Oral SCC is the most common malignant oral tumor in dogs in some studies and frequently invades underlying bone, causing tooth loosening, facial deformity, and difficulty eating. Subungual SCC arises from the epithelium of the nail bed and often presents as a swollen, painful digit that may be initially mistaken for an infection or trauma. Both oral and digital SCC have higher metastatic potential than typical cutaneous lesions, particularly to regional lymph nodes and lungs.

Chronic ultraviolet radiation exposure is the best-documented risk factor for cutaneous squamous cell carcinoma in dogs. Ultraviolet B radiation causes direct DNA damage in keratinocytes, leading to mutations in tumor suppressor genes and oncogenes that govern cell growth and division. Dogs that spend significant time outdoors in sunny climates, particularly those with lightly pigmented skin and sparse or thin hair coats, accumulate UV damage over time that progressively increases their risk of malignant transformation. The ventral abdomen, inguinal region, and other areas with minimal hair coverage are especially susceptible because they lack the photoprotection provided by a dense coat.

Breed predisposition plays an important role in SCC risk, though the specific genetic factors underlying breed susceptibility are not fully characterized. Dalmatians, Bull Terriers, Beagles, and Whippets are overrepresented among dogs diagnosed with UV-associated cutaneous SCC, likely reflecting their light pigmentation and relatively thin hair coats. For subungual SCC, large-breed dogs with dark coats including Standard Poodles, Labrador Retrievers, Rottweilers, Giant Schnauzers, and Dachshunds appear to be disproportionately affected, suggesting a genetic predisposition independent of UV exposure. The striking breed predilection for digital SCC in dark-coated large breeds implies underlying genetic factors that have yet to be identified.

Papillomavirus infection has been implicated in the development of some squamous cell carcinomas in dogs, particularly multicentric cutaneous SCC and some oral lesions. Canine papillomaviruses can integrate their DNA into host cell genomes, producing viral oncoproteins that interfere with normal cell cycle regulation and tumor suppression. While the majority of canine papillomavirus infections are benign and self-limiting, certain viral types or host immune deficiencies may promote malignant progression. The role of papillomavirus in canine SCC is an active area of research and may eventually lead to preventive vaccination strategies.

Chronic inflammation, scarring, and non-healing wounds have been associated with SCC development in both dogs and humans. Burn scars, chronic dermatitis, and areas of repeated trauma or irritation may undergo malignant transformation over time through mechanisms related to sustained cellular proliferation and inflammatory signaling. Immunosuppression from any cause, including chronic corticosteroid therapy, chemotherapeutic agents, or concurrent immunosuppressive diseases, may also increase SCC risk by impairing the immune surveillance mechanisms that normally detect and eliminate early malignant cells.

The clinical presentation of squamous cell carcinoma in dogs varies significantly depending on the anatomic location and stage of the tumor. Cutaneous SCC on sun-exposed skin typically begins as a small area of erythema, scaling, or crusting that may resemble a superficial wound or dermatitis. As the lesion progresses, it may develop into a raised, firm nodule or an ulcerated, crater-like mass with irregular borders and a friable surface that bleeds easily when disturbed. The surrounding skin may show signs of chronic actinic damage including thickening, discoloration, and additional precancerous lesions called actinic keratoses.

Nasal planum SCC is a specific and relatively common presentation, particularly in dogs with unpigmented or partially pigmented noses. Early lesions may appear as persistent crusting, depigmentation, or superficial erosions on the nose that fail to heal with standard wound care. Over time, the lesion progresses to deeper ulceration with tissue destruction, discharge, and occasional hemorrhage. The erosive nature of nasal SCC can cause significant facial disfigurement and discomfort as it destroys the nasal architecture, and the cosmetic and functional impact can be substantial if not addressed early in the disease course.

Oral squamous cell carcinoma most commonly presents as a mass on the gingiva, tongue, tonsils, or palate. Owners may notice halitosis, excessive drooling, blood-tinged saliva, difficulty eating or reluctance to chew, dropping food from the mouth, facial swelling, or loose teeth. Because oral tumors often invade the underlying mandible or maxilla, tooth loosening and jaw pain are frequent findings on veterinary examination. Advanced oral SCC may cause pathological fractures of the jaw, difficulty swallowing, and significant weight loss due to impaired ability to eat.

Subungual SCC affecting the nail bed typically presents as swelling of a single digit, often with loss or deformity of the associated nail. The affected toe may appear red, swollen, and painful, and the dog may limp or favor the affected foot. Chronic licking of the affected digit is common. Because the initial presentation closely resembles a nail bed infection or traumatic injury, subungual SCC is frequently misdiagnosed and treated with antibiotics before the correct diagnosis is established. A toe that fails to respond to appropriate antimicrobial therapy or that shows progressive swelling and bone destruction on radiographs should be strongly suspected for neoplasia and biopsied promptly.

Definitive diagnosis of squamous cell carcinoma requires histopathological examination of tissue obtained through biopsy. Fine needle aspiration cytology can provide preliminary information suggesting squamous cell origin but lacks the architectural detail necessary for definitive diagnosis, grading, and assessment of surgical margins. Incisional biopsy, in which a representative portion of the mass is collected for histopathology, is preferred for large tumors or those in anatomically complex locations where treatment planning benefits from a confirmed diagnosis before definitive surgery. Excisional biopsy, where the entire mass is removed and submitted for analysis, is appropriate for small, accessible lesions where complete excision is feasible as a first approach.

Histopathological examination reveals nests, cords, and sheets of malignant squamous epithelial cells invading the underlying dermis or submucosa. The degree of keratinization, the presence of keratin pearls, cellular atypia, mitotic rate, and depth of invasion all contribute to tumor grading, which ranges from well-differentiated tumors that closely resemble normal squamous epithelium to poorly differentiated or anaplastic tumors with minimal squamous features. Tumor grade has prognostic significance, as poorly differentiated tumors generally behave more aggressively with higher rates of local recurrence and metastasis.

Once a diagnosis of SCC is confirmed, clinical staging is performed to assess the extent of disease and guide treatment planning. Staging typically includes thoracic radiographs in three views to evaluate for pulmonary metastases, regional lymph node evaluation through palpation and fine needle aspiration cytology, and advanced imaging of the primary tumor site as indicated. Computed tomography is particularly valuable for oral and nasal SCC, where the extent of bone involvement often exceeds what is apparent on physical examination and determines the feasibility and approach of surgical resection.

For subungual SCC, radiographs of the affected digit are essential and typically reveal osteolysis of the distal phalanx, which helps distinguish neoplasia from infection. Additional staging with thoracic radiographs and regional lymph node evaluation follows confirmed diagnosis. The staging results inform prognosis and guide treatment decisions, as dogs with confirmed metastatic disease at diagnosis have a substantially different outcome trajectory than those with localized tumors amenable to complete surgical excision.

Surgery is the primary treatment modality for most forms of canine squamous cell carcinoma and offers the best chance of long-term control or cure when complete excision with adequate margins is achievable. For cutaneous SCC, wide surgical excision with margins of one to two centimeters of grossly normal tissue around the tumor is generally recommended. The adequacy of surgical margins is confirmed through histopathological examination of the excised specimen, and incomplete excision is associated with a significantly higher risk of local recurrence, necessitating either revision surgery or adjunctive radiation therapy.

Digital amputation is the standard of care for subungual SCC and carries a favorable prognosis when the disease is confined to the digit. Amputation of the affected toe, including the entire third phalanx and associated soft tissues, achieves complete tumor removal in the majority of cases. Most dogs adapt well to the loss of a single digit and return to normal function with minimal long-term lameness. The reported median survival time following digital amputation for subungual SCC exceeds one to two years, with many dogs surviving significantly longer, particularly when metastatic disease is not present at diagnosis.

Oral SCC presents greater surgical challenges due to the complex anatomy of the mouth and the tumor's propensity for bone invasion. Mandibulectomy or maxillectomy, the surgical removal of a portion of the lower or upper jaw, is often required to achieve adequate margins for gingival SCC with bone involvement. While these procedures may sound dramatic, dogs generally tolerate partial jaw resection remarkably well, with good cosmetic and functional outcomes in experienced surgical hands. Rostral mandibulectomy tends to have better functional outcomes than caudal resections, and maxillectomy patients typically resume eating within a few days of surgery.

Radiation therapy is an important treatment option for SCC, both as a primary modality for non-resectable tumors and as adjunctive therapy following incomplete surgical excision. Squamous cell carcinomas are generally considered radiation-responsive tumors, and definitive radiation protocols using multiple fractions delivered over several weeks can achieve good local control rates, particularly for nasal and oral SCC. Palliative radiation using fewer fractions at higher doses per fraction can provide meaningful symptom relief and improved quality of life for dogs with advanced or inoperable tumors where cure is not a realistic objective.

The role of chemotherapy in the management of canine squamous cell carcinoma is less well defined than for some other tumor types, and systemic chemotherapy is generally considered adjunctive rather than primary therapy for most SCC presentations. However, chemotherapy may be indicated in specific clinical scenarios including non-resectable tumors, incompletely excised tumors where additional surgery or radiation is not feasible, and cases with confirmed or suspected metastatic disease.

Carboplatin and cisplatin are the platinum-based chemotherapy agents most commonly used for canine SCC. These drugs work by forming cross-links within DNA strands, inhibiting DNA replication and triggering apoptosis in rapidly dividing tumor cells. Carboplatin is generally preferred over cisplatin due to its lower nephrotoxic potential, though adequate hydration protocols must still be maintained. Piroxicam and other nonsteroidal anti-inflammatory drugs with cyclooxygenase-2 inhibitory activity have shown antitumor effects against SCC in both in vitro studies and clinical reports, likely through mechanisms involving inhibition of tumor angiogenesis, promotion of apoptosis, and modulation of the tumor microenvironment.

Intralesional chemotherapy, where chemotherapeutic agents are injected directly into the tumor mass, offers the advantage of achieving high local drug concentrations while minimizing systemic side effects. Intralesional carboplatin, often formulated in a sesame oil vehicle to prolong local drug retention, has been used with reported success for cutaneous and nasal SCC in dogs. Electrochemotherapy, which combines intralesional chemotherapy with the application of electrical pulses to increase drug uptake by tumor cells through electroporation, is an emerging modality that has shown promising results for superficial tumors including SCC.

Immunotherapy approaches are an area of active investigation in veterinary oncology. Therapeutic vaccines designed to stimulate the immune system against tumor-associated antigens, checkpoint inhibitor therapies that release the brakes on anti-tumor immune responses, and adoptive cell therapy strategies are all under development or in early clinical trials for various canine cancers. While these approaches are not yet standard of care for canine SCC, the growing understanding of tumor immunology and the availability of novel immunotherapeutic agents suggest that immune-based treatments may play an increasingly important role in the management of squamous cell carcinoma in dogs in the coming years.

The prognosis for squamous cell carcinoma in dogs varies dramatically based on the anatomic location of the primary tumor, making site-specific prognostic information essential for guiding treatment decisions and setting owner expectations. Cutaneous SCC arising on sun-exposed skin generally carries the most favorable prognosis among the common presentations. With complete surgical excision, local cure rates exceed 85 to 90 percent, and metastatic rates for well-differentiated cutaneous SCC are typically below 20 percent. Dogs with incompletely excised cutaneous SCC may still achieve long-term control with adjunctive radiation therapy.

Nasal planum SCC has a variable prognosis depending on the extent of disease at diagnosis and the treatment modality employed. Early, superficial lesions respond well to aggressive local therapy including surgery, radiation, photodynamic therapy, or cryotherapy, with reported control times of one to several years. Advanced nasal SCC with deep tissue invasion carries a more guarded prognosis and may require partial nasal planectomy combined with radiation therapy for optimal control. Despite the cosmetic impact of nasal surgery, most dogs adapt well and maintain good quality of life after treatment.

Subungual SCC has a moderately favorable prognosis following digital amputation, with reported median survival times of approximately one to two years and one-year survival rates of 60 to 90 percent depending on the study. However, roughly 10 to 30 percent of dogs with subungual SCC develop metastatic disease, most commonly to regional lymph nodes and lungs, which significantly worsens the prognosis. Dogs presenting with multiple affected digits have a poorer prognosis than those with a single digit involved, and some of these multicentric presentations may represent metastatic rather than independent primary tumors.

Oral SCC carries the most variable prognosis within the SCC spectrum. Rostral mandibular tumors that are amenable to complete surgical resection with mandibulectomy have reported median survival times of one to two years or longer with surgery alone. However, caudal mandibular and maxillary tumors, tonsillar SCC, and tumors with confirmed lymph node metastasis at diagnosis carry substantially poorer prognoses, with median survival times often measured in months rather than years. Tonsillar SCC is particularly aggressive, with high metastatic rates and poor overall survival despite multimodal therapy.

Breed predisposition to squamous cell carcinoma in dogs follows distinct patterns that correspond to the different anatomic forms of the disease. Understanding these breed-specific risks helps veterinary practitioners maintain appropriate vigilance for early detection in predisposed populations and guides discussions with owners about monitoring and preventive strategies.

For UV-associated cutaneous SCC, breeds with light or white skin and sparse hair coats are disproportionately affected. Dalmatians represent one of the highest-risk breeds due to their white base coat, relatively thin hair, and the extensive areas of unpigmented skin on their ventral surfaces. Bull Terriers, particularly white Bull Terriers, share a similar risk profile. Beagles, Whippets, Italian Greyhounds, and American Staffordshire Terriers are also overrepresented in studies of cutaneous SCC. Pit Bull type dogs with large areas of white or lightly pigmented skin on the abdomen and inner thighs frequently develop actinic keratoses and cutaneous SCC with chronic sun exposure.

Subungual SCC shows a strikingly different breed predisposition pattern that does not correlate with coat color or UV exposure. Large-breed dogs with dark pigmented coats, including Standard Poodles, Giant Schnauzers, Labrador Retrievers, Rottweilers, and Briards, are disproportionately affected by nail bed tumors. This breed distribution has led researchers to investigate potential genetic factors independent of UV damage that may predispose certain breeds to squamous cell transformation in the digital epithelium. The dark coat association with subungual SCC remains one of the intriguing paradoxes in veterinary oncology.

Oral SCC does not show as strong a breed predisposition as the cutaneous and digital forms, though some studies have reported higher rates in certain breeds. Large-breed dogs appear to be affected more frequently than small breeds in some populations. The relatively consistent occurrence across breeds suggests that the risk factors for oral SCC may be more environmental or stochastic than genetic, though the possibility of breed-related differences in oral immune surveillance or epithelial biology cannot be excluded. Regardless of breed, any persistent oral mass, non-healing oral lesion, or unexplained tooth loosening in a dog warrants prompt veterinary evaluation and biopsy to rule out malignancy.

Receiving a diagnosis of squamous cell carcinoma in a beloved dog is understandably distressing for pet owners, and navigating the treatment journey requires both emotional resilience and practical planning. The initial period after diagnosis is often the most overwhelming, as owners must absorb complex medical information, weigh treatment options, consider financial implications, and make decisions under time pressure. Veterinary oncologists and general practitioners can help by providing clear, honest prognostic information, outlining all reasonable treatment options including palliative care, and supporting the owner's decision-making process without judgment.

Financial planning is an important practical consideration, as cancer treatment in veterinary medicine can involve significant costs. Surgical procedures, particularly mandibulectomy or maxillectomy for oral SCC, require specialized surgical expertise and post-operative care. Radiation therapy typically involves multiple treatment sessions under general anesthesia over several weeks and is generally available only at veterinary teaching hospitals or specialty referral practices. Discussing expected costs upfront, exploring payment plans or veterinary financing options, and considering pet insurance coverage if applicable helps owners make informed decisions that balance their dog's medical needs with their financial realities.

Quality of life monitoring is paramount throughout the treatment and recovery process. Dogs undergoing treatment for SCC should be assessed regularly for pain, appetite, mobility, interaction with family members, and overall enjoyment of daily activities. Pain management using multimodal analgesic protocols should be prioritized, as uncontrolled pain significantly diminishes quality of life and may reduce appetite and activity levels. Owners are often the best assessors of their dog's quality of life and should be encouraged to maintain a daily diary tracking key indicators such as appetite scores, activity levels, and pain behaviors to help identify trends and guide treatment adjustments.

For dogs with advanced or metastatic SCC where curative intent treatment is not feasible, palliative care focused on maintaining comfort and quality of life is a valid and compassionate approach. Palliative radiation, pain management, nutritional support, and attentive nursing care can provide meaningful weeks to months of comfortable life for dogs with incurable cancer. The decision about when to consider humane euthanasia is deeply personal and should be guided by the dog's quality of life rather than by arbitrary timelines or milestones. Veterinary professionals can help owners recognize the signs that their dog's quality of life has deteriorated beyond what can be meaningfully improved, and can provide compassionate support through this difficult transition.

Preventing squamous cell carcinoma in dogs is possible to a meaningful degree for the UV-associated cutaneous form, though prevention strategies for oral and subungual SCC remain limited due to incomplete understanding of their etiologies. Reducing chronic ultraviolet radiation exposure is the most impactful preventive measure for dogs at risk of cutaneous SCC. Limiting outdoor time during peak UV hours, typically between 10 AM and 4 PM, provides significant protection. For dogs that must be outdoors during these hours, providing shaded rest areas and applying pet-safe sunscreen to exposed, unpigmented skin areas including the nose, ear tips, and ventral abdomen can reduce cumulative UV damage.

Pet-safe sunscreens should be specifically formulated for use on animals, as many human sunscreen products contain zinc oxide or para-aminobenzoic acid, which can be toxic to dogs if ingested through grooming. Sunscreen should be applied to vulnerable areas thirty minutes before sun exposure and reapplied every two hours or after swimming or heavy panting. Sun-protective clothing, including lightweight UV-blocking shirts and suits designed for dogs, offers an alternative or complementary approach to sunscreen for dogs that resist topical application or groom the product off before it provides adequate protection.

Early detection through regular veterinary examinations and owner vigilance is critical for all forms of SCC. Owners of predisposed breeds should be educated about the appearance of early skin lesions and encouraged to report any persistent sore, non-healing wound, pigmentation change, or lump to their veterinarian promptly. Monthly at-home skin checks, where the owner systematically examines the entire skin surface including the ventral abdomen, inner thighs, nail beds, oral cavity, and ears, can identify suspicious lesions early when treatment is most likely to be successful.

Veterinary dental examinations and oral inspections performed at least annually provide opportunities to detect oral SCC at an early stage. Because many dogs resist thorough oral examination while awake, evaluation of the oral cavity under sedation or anesthesia during routine dental cleanings offers a valuable chance for complete visual and tactile assessment. Any oral mass, area of gingival irregularity, or unexplained tooth loosening identified during dental procedures should be biopsied. Similarly, any digit that is chronically swollen, painful, or has a deformed or missing nail should be radiographed and biopsied rather than simply treated empirically with antibiotics, as early diagnosis of subungual SCC significantly improves the chances of curative treatment through digit amputation before metastatic spread occurs.